The Bahrain Oncology Centre has made medical history by successfully treating a sickle cell disease patient using CRISPR-based gene-editing therapy, Casgevy. This marks the...
New York City Blood Center Enterprises today announced that their researchers have uncovered a critical mechanism that could potentially transform treatment approaches for Sickle...
